ArticlePloS one2021

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.

Long-Sheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.